COSCIENS Biopharma Inc. Common Stock
CSCI
CSCI was delisted on the 3rd of September, 2025.
17 hedge funds and large institutions have $8.97M invested in COSCIENS Biopharma Inc. Common Stock in 2015 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 6 closing their positions.
826% more capital invested
Capital invested by funds: $969K → $8.97M (+$8M)
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
6% less funds holding
Funds holding: 18 → 17 (-1)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$4.88M |
| 2 |
TCM
Tenor Capital Management
New York
|
+$3.28M |
| 3 |
DM
Deerfield Management
New York
|
+$516K |
| 4 |
Renaissance Technologies
New York
|
+$310K |
| 5 |
Millennium Management
New York
|
+$86K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$287K |
| 2 |
Two Sigma Investments
New York
|
-$61K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$54K |
| 4 |
Morgan Stanley
New York
|
-$45.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$25K |
CSCI Hedge Fund Activity: Q1 2015 in Review
17 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in COSCIENS Biopharma Inc. Common Stock (CSCI) for Q1 2015, worth a combined $8.97M — up 826% from $969K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of CSCI and 5 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 4 added.
The largest buyer was Susquehanna International Group, adding an estimated $4.88M. The largest seller was Hudson Bay Capital Management, cutting an estimated $287K.
- 17 institutional investors held COSCIENS Biopharma Inc. Common Stock (CSCI) as of Q1 2015, down from 18 in Q4 2014.
- Funds reported $8.97M of COSCIENS Biopharma Inc. Common Stock stock for Q1 2015, up 826% quarter-over-quarter.
- 5 funds opened new COSCIENS Biopharma Inc. Common Stock positions in Q1 2015 and 6 closed out, a net change of -1 holder.
- The largest COSCIENS Biopharma Inc. Common Stock buyer in Q1 2015 was Susquehanna International Group, an estimated $4.88M added.
- The largest COSCIENS Biopharma Inc. Common Stock seller in Q1 2015 was Hudson Bay Capital Management, an estimated $287K sold.
Based on aggregated 13F filings for Q1 2015.